USPTO serial 79125954
METIV
Reviewed by CopyMark Law Group
Reg. 4374280Status 404
- Filing date
- Status date
- Registration date
- Jul 30, 2013
- Examiner
- HOFFMAN, DAVID AARON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with METIV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Conducting of clinical studies and trials of pharmaceuticals; providing information on clinical studies and trials of pharmaceuticals | SECTION 71 - CANCELLED | — |
| 044 | Providing medical information in the field of pharmaceutical preparations; providing medical information on the efficacy, side effects, interactions or administration of pharmaceutical preparations | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named METIV
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 19, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jul 19, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 2, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 27, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 27, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 27, 2022 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Oct 22, 2014 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Oct 16, 2014 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 14, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 29, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 29, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 29, 2013 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Jul 30, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 15, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 14, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 24, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 24, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 24, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 8, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 3, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 8, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 4, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 1, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Feb 28, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |